HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bcl-xL controls a switch between cell death modes during mitotic arrest.

Abstract
Antimitotic agents such as microtubule inhibitors (paclitaxel) are widely used in cancer therapy while new agents blocking mitosis onset are currently in development. All these agents impose a prolonged mitotic arrest in cancer cells that relies on sustained activation of the spindle assembly checkpoint and may lead to subsequent cell death by incompletely understood molecular events. We have investigated the role played by anti-apoptotic Bcl-2 family members in the fate of mitotically arrested mammary tumor cells treated with paclitaxel, or depleted in Cdc20, the activator of the anaphase promoting complex. Under these conditions, a weak and delayed mitotic cell death occurs that is caspase- and Bax/Bak-independent. Moreover, BH3 profiling assays indicate that viable cells during mitotic arrest are primed to die by apoptosis and that Bcl-xL is required to maintain mitochondrial integrity. Consistently, Bcl-xL depletion, or treatment with its inhibitor ABT-737 (but not with the specific Bcl-2 inhibitor ABT-199), during mitotic arrest converts cell response to antimitotics to efficient caspase and Bax-dependent apoptosis. Apoptotic priming under conditions of mitotic arrest relies, at least in part, on the phosphorylation on serine 62 of Bcl-xL, which modulates its interaction with Bax and its sensitivity to ABT-737. The phospho-mimetic S62D-Bcl-xL mutant is indeed less efficient than the corresponding phospho-deficient S62A-Bcl-xL mutant in sequestrating Bax and in protecting cancer cells from mitotic cell death or yeast cells from Bax-induced growth inhibition. Our results provide a rationale for combining Bcl-xL targeting to antimitotic agents to improve clinical efficacy of antimitotic strategy in cancer therapy.
AuthorsN Bah, L Maillet, J Ryan, S Dubreil, F Gautier, A Letai, P Juin, S Barillé-Nion
JournalCell death & disease (Cell Death Dis) Vol. 5 Pg. e1291 (Jun 12 2014) ISSN: 2041-4889 [Electronic] England
PMID24922075 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ABT-737
  • BAX protein, human
  • BCL2L1 protein, human
  • Biphenyl Compounds
  • Nitrophenols
  • Piperazines
  • Sulfonamides
  • bcl-2-Associated X Protein
  • bcl-X Protein
Topics
  • Amino Acid Substitution
  • Apoptosis
  • Biphenyl Compounds (pharmacology)
  • Breast Neoplasms (drug therapy, genetics, metabolism, pathology)
  • Cell Cycle Checkpoints
  • Cell Line, Tumor
  • Female
  • Humans
  • Mitochondria (genetics, metabolism, pathology)
  • Mutation, Missense
  • Nitrophenols (pharmacology)
  • Piperazines (pharmacology)
  • Sulfonamides (pharmacology)
  • bcl-2-Associated X Protein (genetics, metabolism)
  • bcl-X Protein (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: